AXL and hepatocellular carcinoma: Nuclear serine/threonine kinases NUAK1/2, signal transducer and activator of transcription 3, yes-associated protein 1 and frizzled-2 are capable of inducing Axl expression in about 40% of HCC cases [6,7,8,9].